1. What Is the Oncology Care Model Market?
The Oncology Care Model Market covers alternative payment programmes, value-based care platforms, and care coordination tools enabling oncology practices to deliver cost-efficient, patient-centred cancer care under performance-based reimbursement models. Oncology care model encompasses CMS OCM alternative payment model software, oncology navigator platforms, care coordination tools, and financial toxicity management services. Market dynamics reflect CMS Enhancing Oncology Model replacing OCM in 2023, commercial payer oncology alternative payment model expansion, and cancer care management platform growth supporting value-based oncology transition.
2. Oncology Care Model Market Size & Forecast
3. Emerging Technologies
- AI-driven oncology treatment pathway software automating clinical decision support for on-pathway therapy selection are advancing as care standardisation tools. Growing adoption at oncology practices is driven by commercial payer pathway compliance requirements.
- Financial toxicity screening platforms identifying cancer patients at risk for financial distress enabling proactive counselling are advancing. Growing adoption is driven by CMS quality measure reporting and commercial payer care management requirements.
- Oncology care management platforms integrating clinical, financial, and social determinant data for at-risk patient identification are advancing. Growing adoption at oncology APM participants is driven by cost reduction performance measure requirements.
- Remote patient monitoring integration with oncology care model platforms enabling between-visit symptom management are advancing. Growing adoption at oncology practices is driven by patient engagement and adverse event prevention requirements.
Comparable technologies are influencing adjacent market segments in similar ways. Read more in our Cancer Registry Market.
4. Key Market Opportunity
The highest-value opportunity in the Oncology Care Model Market is the oncology care management software sub-market, where CMS EOM and commercial APM compliance drives oncology practice software investment. Oncology navigator services create a recurring care coordination revenue channel as practices demonstrate clinical and financial value. Financial toxicity management creates a growing service opportunity as cancer financial counselling becomes a standard oncology care component. Asia Pacific oncology care model creates geographic expansion as Japanese and Korean oncology value-based care payment models develop.
5. Top Companies in the Oncology Care Model Market
The following organisations hold leading positions in the Oncology Care Model Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- McKesson Specialty Health
- Flatiron Health (Roche)
- Epic
- Navigating Cancer
- Carevive
- Outcomes4Me
- MedVantx
- MyCancerCoach
- Eviti (eviCore)
- Komodo Health
6. Market Segmentation
The Oncology Care Model Market is analysed across 4 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By Solution | APM Software Care Coordination Oncology Navigator Financial Counselling |
| By Payer | Medicare CMS Commercial Payer Medicaid Self-Insured Employer |
| By Practice | Community Oncology Academic Centre Health System |
| By Geography | North America Europe Asia Pacific Latin America Middle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the Oncology Care Model Market trajectory over the forecast period:
CMS Enhancing Oncology Model Achieves 100 Oncology Practice Participants Across Nine Cancer Types.CMS Enhancing Oncology Model launched July 2023 achieving 100 participating practices across nine cancer types in 2024 demonstrates value-based oncology model expansion. EOM performance year 1 data showing 3 percent expenditure reduction versus benchmark demonstrates early value-based oncology payment model performance.
Commercial Payer Oncology APM Programmes Reach USD 8 Billion in At-Risk Commercial Oncology Spend.Blue Cross Blue Shield and UnitedHealth Group oncology alternative payment model programmes covering USD 8 billion in at-risk commercial oncology spend in 2024 demonstrate commercial payer value-based oncology adoption. BCBS commercial oncology pathway compliance requirements exceeding 80 percent across 500 oncology practices demonstrate payer-driven pathway adherence at scale.
Oncology Navigator Programmes Demonstrate 15 Percent Emergency Department Visit Reduction in High-Risk Cancer Patients.Patient navigator programmes at comprehensive cancer centres demonstrating 15 percent ED visit reduction and 20 percent hospital admission reduction in high-risk cancer patients in 2024 demonstrate care coordination value. Navigator programme ROI demonstrating USD 4 cost avoidance per USD 1 navigation investment validates the care coordination economic case for payer and practice investment.
For related market intelligence, see the Lung Cancer Therapeutics Market.
8. Segmental Analysis
By solution, the APM Software and Clinical Decision Support segment dominated the Oncology Care Model Market in 2025. Representing the largest revenue category as oncology practices invest in pathway compliance software. The Oncology Navigator Programme segment is the fastest-growing category, advancing as care coordination ROI demonstration drives programme expansion across cancer centre networks.
By payer, the CMS Medicare segment dominated the Oncology Care Model Market in 2025. Representing the largest payer revenue share. The Commercial Payer APM segment is the fastest-growing payer category, advancing as clinical protocol standardisation and reimbursement expansion broaden market access. Both payer dimensions indicate active transition between established CMS Medicare demand and emerging Commercial Payer APM adoption.
By practice type, the Community Oncology segment dominated the Oncology Care Model Market in 2025, as independent community oncology practices participating in CMS value-based oncology programmes generate the largest OCM care episode volume. Academic Centre is the fastest-growing category, driven by major cancer centres entering value-based care arrangements and applying multidisciplinary team coordination for complex case management.
9. Regional Analysis
Regional demand patterns across the Oncology Care Model Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America accounted for the largest share of the Oncology Care Model Market in 2025, holding 48.7% of the global market. Oncology practices, integrated delivery networks, and oncology value-based care organisations are deploying care model platforms to manage episodes of care, track quality metrics, and optimise treatment pathway compliance. CMS Oncology Care Model and Enhancing Oncology Model programme participation requirements and growing insurer value-based oncology contract adoption are encouraging cancer programme investment in care model management platforms. High oncology spending, established value-based care infrastructure, and growing CMS oncology payment model programme participation are generating strong regional oncology care model demand.
Highest CAGR Region
Europe is expected to register the highest CAGR of 11.34% during the forecast period. European oncology centres, integrated cancer networks, and health technology assessment organisations across Germany, France, the Netherlands, and the Nordic countries are deploying oncology care model programmes aligned with national cancer control plans. European health authority requirements for value-based cancer care and growing demand for patient-reported outcome integration in cancer pathway management are encouraging care model adoption. Rising healthcare efficiency requirements and increasing adoption of multidisciplinary tumour board clinical decision processes are generating European oncology care model demand.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology Adoption Trends and Innovation Tracking
- • Custom Company Profiling and Benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country-Level Opportunity Mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The Oncology Care Model Market was valued at USD 4.51 Bn in 2025 and is projected to reach USD 9.55 Bn by 2034, growing at a CAGR of 8.7% over the 2026–2034 forecast period.
The Oncology Care Model Market is projected to grow at a CAGR of 8.7% from 2026 to 2034.
North America accounted for the largest share of the Oncology Care Model Market in 2025, holding 48.7% of the global market.
The leading companies in the Oncology Care Model Market include McKesson Specialty Health, Flatiron Health (Roche), Epic, Navigating Cancer, Carevive, Outcomes4Me, MedVantx, MyCancerCoach, Eviti (eviCore), Komodo Health.
Cms enhancing oncology model achieves 100 oncology practice participants across nine cancer types.
By solution, the APM Software and Clinical Decision Support segment dominated the Oncology Care Model Market in 2025.
How to Order
Purchasing a TrendX Insights report is straightforward. Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.
This is the price of the syndicated report. Any custom inclusions beyond the Table of Contents will be scoped and priced separately. For the full list of what is covered in the syndicated report, refer to the Table of Contents tab.
A curated, condensed version of this report for students, researchers, and academic institutions. Ideal for thesis work, dissertations, and academic projects. Delivered as PDF to your institutional email.
Valid student ID or institutional email required. For educational and non-commercial use only.